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In 2004, two seminal papers focused on the role of AMP-activated protein kinase (AMPK)
in the hypothalamus opened new avenues of research in the field of the central reg-
ulation of energy homeostasis. Over the following 8 years, hundreds of studies have
firmly established hypothalamic AMPK as a key sensor and integrator of hormonal and
nutritional signals with neurochemical and neurophysiological responses to regulate whole-
body energy balance. In this review article we aim to discuss the most recent findings
in this particular area of research, highlighting the function of hypothalamic AMPK in
appetite, thermogenesis, and peripheral glucose metabolism.The diversity of mechanisms
by which hypothalamic AMPK regulates energy homeostasis illustrates the importance of
this evolutionary-conserved energy signaling cascade in the control of this complex and
fundamental biological process.
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INTRODUCTION
AMP-activated protein kinase is an evolutionary-conserved het-
erotrimeric serine/threonine protein kinase that acts as a cellular
and organismal energy sensor, regulating systemic metabolism
through multiple effects in different tissues (Hardie et al., 2012).
In the hypothalamus, AMPK is a central mediator of the adaptive
responses to physiological regulation of feeding behavior through
the integration of hormonal and nutritional cues (Blanco Mar-
tinez de Morentin et al., 2011). In general terms, orexigenic signals
(fasting, hypoglycemia, ghrelin, etc.) in the hypothalamus acti-
vate AMPK, while anorexigenic signals (feeding, hyperglycemia,
insulin, leptin, etc.) exert the opposite effect (Minokoshi et al.,
2004; Blanco Martinez de Morentin et al., 2011). However, the
hypothalamus is composed of different nuclei and neuronal pop-
ulations with specific functions, and therefore it is important to
delineate the role of AMPK in discrete subpopulations of neu-
rons. In an attempt to address this, we generated mice with a
conditional deletion of the α2 catalytic subunit of AMPK in key
neuronal populations of the arcuate nucleus of the hypothala-
mus (ARC), namely pro-opiomelanocortin (POMC) and agouti-
related protein (AgRP) neurons (Claret et al., 2007). Our data
demonstrated critical but divergent effects on energy balance when
AMPK was deleted in POMC or AgRP neurons, suggesting that
AMPK plays specific roles in particular populations of neurons
rather than being a general integrator of energy homeostasis in
the hypothalamus. Furthermore, our study also revealed an essen-
tial glucose-sensing function for AMPK in both POMC and AgRP
neurons (Claret et al., 2007). Although studies targeting discrete
populations of neurons are further required, the bulk of stud-
ies performed to date firmly establish hypothalamic AMPK as a
critical sensor and integrator of nutrient and hormonal-related
signals implicated in whole-body energy homeostasis. The aim of
this review article is not to exhaustively discuss the role of hypo-
thalamic AMPK in energy homeostasis control, but to introduce
the most recent findings and concepts exploring this fundamental
regulatory system.
HYPOTHALAMIC AMPK AND APPETITE REGULATION
The regulation of AMPK activity is complex, but mainly achieved
through phosphorylation of threonine172 on the catalytic α sub-
unit by upstream kinases, such as liver kinase B1 (LKB1) and
Ca2+/Calmodulin kinase kinase β (CamKKβ; Hardie et al., 2012).
A recent study has reported that inositol polyphosphate multiki-
nase (IPMK) may be an upstream physiologic regulator of AMPK
activity in the hypothalamus (Bang et al., 2012). IPMK inhibits
AMPK activity during the fasting/refed transition through bind-
ing between these two proteins, an interaction facilitated by IPMK
phosphorylation on tyrosine174. The working hypothesis is that
the AMPK/IPMK complex is a worse substrate than AMPK alone
for upstream kinases such as LKB1, and/or is more susceptible
to protein phosphatases thus preventing AMPK phosphoryla-
tion and activation (Figure 1). The binding of IPMK to AMPK
might represent an additional and perhaps physiologically rele-
vant mechanism of AMPK activity regulation. In this regard, it
would be interesting to explore the identity of the kinase that
phosphorylates IPMK, and also if this event is also modulated by
metabolic hormones or other nutrients. These findings emphasize
the importance of a fine-tuning balance of the phosphorylation
status of threonine172 to exert the diversity of AMPK functions,
and suggest a potential target to modulate AMPK activity.
Another putative regulator of AMPK activity is kinase suppres-
sor of Ras 2 (KSR2). This protein likely functions as a molecular
scaffolding, rather than a kinase, that binds to AMPK (Costanzo-
Garvey et al., 2009; Liu et al., 2009). Two studies have reported the
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FIGURE 1 | Hypothalamic AMPK regulates appetite. Schematic
representation of a generic hypothalamic neuron depicting a summary of
the recently uncovered signaling mechanisms implicated in appetite
control. Pathways in red inhibit AMPK activity and subsequently reduce
food intake and body weight (negative energy balance), while pathways in
green activate it and lead to the opposite physiological outputs (positive
energy balance). A diagram of the role of presynaptic AMPK can be found
elsewhere (Yang et al., 2011; Hardie et al., 2012). LepR, leptin receptor;
Ghsr1a, growth hormone secretagogue receptor type 1a; PI3K,
phosphatidylinositol 3-kinase; Akt, protein kinase B; mTOR, mammalian
target of rapamycin; KSR2, kinase suppressor of Ras 2; PLCβ,
phospholipase C; IP3, inositol-1,4,5-triphosphate; Ca2+, calcium; LKB1,
liver kinase B1; CamKKβ, Ca2+/Calmodulin kinase kinase β; Sirt-1, sirtuin 1;
IPMK, inositol polyphosphate multikinase.
metabolic consequences of global KSR2 deletion with discordant
results. Costanzo-Garvey et al. (2009) suggest that the observed
obesity phenotype in KSR2 knock-out mice is due to reduced fatty
acid oxidation and thermogenesis. In contrast, Revelli et al. (2011)
present evidence of increased body weight mainly due to profound
hyperphagia. Furthermore, while the former report links the phe-
notype to alterations in AMPK activity, the latter study suggests the
involvement of mTOR in this process (Figure 1). These differences
in phenotype may be the result of different genetic backgrounds
and/or gene-targeting events. Additional studies will be required
to assess the relevance of KSR2 as a regulator of AMPK signaling
cascade and nutrient sensor in the hypothalamus.
Some of the most exciting recent findings on the role of hypo-
thalamic AMPK upon energy balance control are related with the
orexigenic hormone ghrelin. The central effects of ghrelin on food
intake and body weight are mediated by AMPK activation in AgRP
neurons of the ARC (Andrews et al., 2008; Lopez et al., 2008). The
current model of action propounds that ghrelin, after binding
its receptor (GHSR1a), increases intracellular Ca2+ stimulating
AMPK activity via CamKKβ activation. However, our knowledge
of the precise molecular mechanisms implicated is still incomplete.
Velasquez et al. have recently reported a novel sequence of events
between the ghrelin receptor and AMPK activation that further
describes this pathway. Using a combination of pharmacological
and genetic approaches, the authors demonstrate that the orexi-
genic action of ghrelin is mediated by a sirtuin 1 (SIRT-1)-p53-
AMPK pathway (Velasquez et al., 2011; Figure 1). It is unknown
whether this pathway converges somehow with CamKKβ or if it
is part of a parallel signaling pathway mediating slightly different
physiological ghrelin effects. Furthermore, this study challenges
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the field suggesting a potential role for p53, a tumor-suppressor
protein widely implicated in cancer, in the central regulation of
metabolism. The study of conditional knock-outs of p53 in spe-
cific populations of neurons will help to expand these exciting
findings.
In contrast to the aforementioned prevailing view, supporting
that ghrelin directly acts on AgRP neurons to exert its orex-
igenic actions, a recent report provides an additional layer of
complexity to the current model. Yang et al. (2011) have used
an elegant combination of electrophysiology, pharmacology, and
optogenetics to unveil a novel presynaptic pathway that stimu-
lates the activity of AgRP neurons. The authors provide evidence
indicating that, under fasting conditions, ghrelin increases presy-
naptic AMPK activity through intracellular Ca2+ release and
subsequent CamKKβ activation. Elevated AMPK activity is able
to further release Ca2+ via ryanodine receptors, thus causing a
positive feedback loop and synaptic hysteresis onto AgRP neu-
rons. This sustained synaptic upregulation induced by ghrelin can
be reversed by the anorexigenic adipokine leptin, which activates
POMC neurons and resets the system by releasing a still undefined
opioid. These results highlight the relevance of AMPK in presy-
naptic neurons, but do not formally exclude the existence of a key
and complementary role for postsynaptic AMPK in the regulation
of energy balance in vivo. In fact, previous studies have shown a
key cell-autonomous role for AMPK in both AgRP and POMC
neurons (Claret et al., 2007). Furthermore, hysteresis for AMPK
does not occur in all cells, so it is likely that appropriate regula-
tion of appetite and body weight is achieved by a combination of
presynaptic and postsynaptic events.
The adipokine leptin is another crucial hormone implicated
in the central regulation of energy balance that exerts its actions
through AMPK. Leptin inhibits AMPK activity in the hypothal-
amus (Andersson et al., 2004; Minokoshi et al., 2004), an effect
that is in contrast with its role in the periphery (Minokoshi et al.,
2002). The signaling events implicated in leptin-induced AMPK
inhibition in the hypothalamus have been recently uncovered by
Dagon et al. (2012). The authors found that phosphorylation
on serine485/491 of AMPKα2 was associated with reduced AMPK
activity in the ARC, ventromedial hypothalamus (VMH), and par-
aventricular nucleus (PVN). This AMPK inhibition, which was
sufficient to regulate appetite and body weight, was independent
of the phosphorylation status of threonine172. These results sug-
gest that serine485/491 may act as an “off switch,” adding a further
level of regulatory sophistication to this already complex system.
Interestingly, p70S6K is the kinase responsible for this inhibitory
phosphorylation on AMPK. Together, these results suggest the
existence of a coordinated leptin-stimulated signaling network
in the hypothalamus that unifies phosphatidylinositol 3-kinase
(PI3K)-AKT, mammalian target of rapamycin (mTOR)-p70S6K,
and AMPK.
HYPOTHALAMIC AMPK AND REGULATION OF GLUCOSE
METABOLISM
The hypothalamus has emerged as a relevant determinant of
whole-body glucose homeostasis through different effects in mus-
cle, pancreas, and liver (Marino et al., 2011). In particular, the role
of hormonal signaling and nutrient sensing in the hypothalamic
control of endogenous glucose production (EGP) has recently
received increasing attention. In this regard, AMPK has been
proposed to mediate some of these effects. For example, AMPK
in the VMH has been implicated in hypoglycemia sensing and
also in non-hormonal, as well as hormonal, counterregulatory
responses to stimulate glucose production (McCrimmon et al.,
2004, 2006, 2008). A novel study, using genetic tools allowing
bidirectional changes in AMPK activity, confirms, and extends
these findings (Yang et al., 2010; Figure 2). Mediobasal hypothal-
amic injection of a dominant negative (DN) isoform of AMPKα
was sufficient to suppress glucose production in rats. Although
the delivery of a constitutive active (CA) AMPKα form did not
produce the opposite effect, it was able to negate the hypo-
thalamic glucose/lactate-sensing mechanisms to reduce glucose
production (Yang et al., 2010). These findings, which were inde-
pendent of changes in the concentration of circulating pancre-
atic hormones, suggest that hypothalamic AMPK is sufficient
and necessary to regulate EGP. However, it is important to bear
in mind that this study was conducted using the pancreatic
euglycemic clamp technique, so the relevance of this regula-
tory system should be further assessed in a more physiological
setting.
It has been recently proposed that the effects of hypothala-
mic AMPK on EGP are downstream mediated by neurons located
at the dorsal vagal complex (DVC) within the hindbrain. N -
methyl-d-aspartate (NMDA) receptor has been implicated in the
intestine nutrient sensing mechanisms regulating glucose produc-
tion (Lam et al., 2010). Interestingly, pharmacological and genetic
inhibition of NMDA receptor in the DVC blunted the ability
of a hypothalamic DN AMPK form to reduce glucose produc-
tion (Lam et al., 2011). This study strengthens the notion that
DVC NMDA receptor-expressing neurons integrate information
from nutrient signals in order to regulate glucose homeostasis
via AMPK, but does not exclude the implication of other neu-
ronal systems in this biological process. In fact, the hypothalamus
can influence additional autonomic nuclei to control whole-body
metabolism (Marino et al., 2011), and thus further investigation is
needed to uncover the extrahypothalamic neuronal networks that
may be involved in the hypothalamic AMPK control of glucose
production.
Leptin and insulin signaling in ARC POMC and AgRP neu-
rons also regulates hepatic glucose fluxes (Marino et al., 2011).
We have previously shown that POMC and AgRP neurons lacking
AMPKα2 became insensitive to alterations in extracellular glu-
cose concentrations, a defect that was associated with alterations
in whole-body energy balance but not glucose metabolism (Claret
et al., 2007). In this regard, recent evidence further indicates that
AMPKα2 is a sensor of glucose fluctuations in a hypothalamic
cell line, possibly through the modulation of uncoupling pro-
tein 2 (UCP2) activity (Beall et al., 2012). Interestingly, POMC
neurons lacking the upstream kinase LKB1 exhibited normal
glucose-sensing, but these mice showed systemic glucose intol-
erance, insulin resistance and impaired HGP with concomitant
upregulation of key gluconeogenic enzymes (Claret et al., 2011;
Figure 2). These metabolic defects were associated with reduced
alpha-melanocyte stimulating hormone (α-MSH) secretion from
POMC neurons. Remarkably, deletion of CamKKβ in POMC
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FIGURE 2 | Hypothalamic AMPK regulates glucose metabolism
and thermogenesis. Nicotine, triiodothyronine (T3), and bone
morphogenetic protein 8B (BMP8B) exert their thermogenic
properties on brown adipose tissue (BAT) through inhibition of
AMPK in the ventromedial hypothalamus (VMH). AMPK in the VMH
also acts as a glucose sensor to modulate endogenous glucose
production. This effect is mediated, at least partially, by the dorsal
vagal complex (DVC). LKB1 in arcuate (ARC) POMC neurons
regulate systemic glucose metabolism through hepatic glucose
production modulation.
neurons did not produce any obvious metabolic phenotype (Claret
et al., 2011).
These divergences in phenotypes can be explained by the fact
that LKB1 is also able to signal through several AMPK-related
kinases other than AMPK. In addition, compensatory mechanisms
aimed to maintain the functionality of the signaling cascade could
also explain these disparities. Similar in vivo examples of pheno-
type divergence can be found in studies targeting AMPK (Beall
et al., 2010; Sun et al., 2010a) or LKB1 (Fu et al., 2009; Gra-
not et al., 2009; Sun et al., 2010b) in pancreatic β-cells. Taken
together our data support the idea that, at least in POMC neurons,
AMPK might be implicated in feeding and energy expenditure
regulation whereas LKB1 would regulate alternative downstream
effectors to control glucose metabolism. This data also suggest that
systemic glucose homeostasis does not necessarily correlate with
glucose-sensing in POMC neurons.
HYPOTHALAMIC AMPK AND REGULATION OF
THERMOGENESIS
Thermogenesis in brown adipose tissue (BAT) is an essential com-
ponent of the energy balance equation. It has been recognized for
a long time that the hypothalamus, and in particular the VMH,
plays a crucial role in the regulation of BAT activity (Cannon and
Nedergaard, 2004). However, the molecular mechanisms mediat-
ing these effects have been elusive for a long time. A number of
excellent reports from the same research group have recently pro-
posed hypothalamic AMPK as a pivotal thermogenic regulator of
BAT through the sympathetic nervous system (SNS).
Whittle and collaborators have studied the metabolic role
of bone morphogenetic protein 8B (BMP8B). This protein was
highly expressed in brown adipocytes and its expression mod-
ulated by different thermogenic stimuli (Whittle et al., 2012).
Mice globally lacking BMP8B exhibited reduced thermogenesis,
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increased body weight, and enhanced propensity for weight gain
when fed with high-fat diet (HFD). BMP8B was also found to
be expressed in the brain and particularly enriched in the ARC
and VMH. Interestingly, the authors observed attenuated acti-
vation of AMPKα in the hypothalamus from knock-out mice
under basal conditions. Intracerebroventricular (ICV) adminis-
tration of BMP8B activated VMH neurons and BAT thermoge-
nesis in rodents. Targeted delivery of a DN isoform of AMPKα
in the VMH resulted in a higher thermogenic effect of ICV
BMP8B administration, whereas expression of CA AMPKα iso-
form blunted BMP8B-stimulated activation of BAT (Whittle et al.,
2012). These results demonstrate that the central thermogenic
action of BMP8B is dependant on hypothalamic AMPK activ-
ity (Figure 2). It is important to note that changes in VMH
AMPK activity only produced thermogenic effects in combina-
tion with BMP8B injection, suggesting that these two proteins
may act as a counterregulatory mechanism to modulate BAT
thermogenesis.
Hypothalamic AMPK has also been critically implicated in
the thermogenic response elicited by thyroid hormones. Lopez
et al. (2010) provided compelling evidence that hyperthyroidism
and ICV triiodothyronine (T3) injection inactivate hypothalamic
AMPK, stimulating de novo lipogenesis, and BAT activity through
the SNS (Figure 2). These effects were inhibited when a CA
AMPKα isoform was specifically delivered to the VMH, indicating
that inhibition of VMH AMPK by thyroid hormones is necessary
to perform their metabolic effects. Together, these evidences high-
light the pathophysiological relevance of this central mechanism
in hyperthyroidism and provide important conceptual advances
in the understanding of this pathology.
The AMPK-BAT axis has also been proposed to mediate the
anorexigenic properties of nicotine. These effects, in both humans
and rodents, have been mostly attributed to central actions but the
molecular mechanisms implicated are poorly understood. Mar-
tinez de Morentin et al. (2012) demonstrate that the negative
energy balance (reduced food intake and increased BAT activity)
induced by nicotine treatment was associated with hypothala-
mic AMPK inhibition and changes in neuropeptide expression. A
combination of pharmacological and genetic approaches proved,
similarly to previous studies, that AMPK in the VMH played a key
role in mediating the nicotine effects, not only on BAT thermo-
genesis but also on food intake. In this sense, it is interesting to
note that, depending on the modulatory affector, AMPK in the
VMH is able to either target BAT thermogenesis (as in hyper-
thyroidism) or both food intake and energy expenditure (after
nicotine treatment). Therefore, it remains to be elucidated the dif-
ferential modulatory effects on AMPK activity and/or signaling
pathways downstream of AMPK that are able to dissociate these
effects.
Collectively, these studies show that different thermogenic
stimuli mediate their effects through modulation of AMPK activity
in the VMH. Thus, it is tempting to speculate that the VMH
AMPK-BAT axis may be a general regulator of BAT activity impli-
cated in energy homeostasis control. Given the current evidence
highlighting the importance of BAT in adult humans (Ravussin
and Galgani, 2011), selective modulation of AMPK activity in
the VMH could represent a strategy to target metabolic disorders
characterized by alterations in energy balance such as obesity.
FUTURE CHALLENGES
Hypothalamic AMPK plays a critical role in energy homeostasis
control through the regulation of appetite, thermogenesis, and
glucose metabolism. The hypothalamus contains different nuclei
and multiple populations of neurons with specific and some-
times opposed functions. However, most of the studies implicating
hypothalamic AMPK in metabolic control have not considered the
diverse nature of the hypothalamus and therefore caution should
be taken when interpreting the current data. In this regard, the use
of targeted approaches to investigate the role of AMPK signaling
cascade in specific subsets of neurons or other central nervous sys-
tem cell types will help to further define its role. Another aspect to
take into account is the AMPK tissue-specific differences in terms
of modulatory activity and metabolic effects. This is an impor-
tant issue that should be considered when designing therapeutical
strategies to target AMPK.
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